Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
| Egile nagusia: | Moreino, Shannon Sherwin |
|---|---|
| Beste egile batzuk: | Kabir, Eva Rahman |
| Formatua: | Project report |
| Hizkuntza: | English |
| Argitaratua: |
BRAC University
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | http://hdl.handle.net/10361/9331 |
Antzeko izenburuak
-
Biologics and Biosimilars as Treatment Options for Psoriasis
nork: Moya, Amena Khatun
Argitaratua: (2023) -
Biosimilar in lymphoma treatment
nork: Tanisha, Mehrin Haque
Argitaratua: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
nork: Tabassum, Turana
Argitaratua: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
nork: Tania, Umme
Argitaratua: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
nork: Tania, Umme
Argitaratua: (2023)